0

Bisantrene dihydrochloride

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP78186342
CAS78186-34-2
Structure
MDL NumberMFCD01743164
Molecular Weight471.39
InChI KeyKINULKKPVJYRON-PVNXHVEDSA-N
Description≥98% (HPLC)
Solubilitydeionized water: 8 mg/mL
Assay≥98% (HPLC)
Formsolid
Size10MG, 50MG
Storage Conditionsroom temp
1

Activation of Tumor-Cytostatic Macrophages With the Antitumor Agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] Dihydrochloride (Bisantrene)

B S Wang, A L Lumanglas, V M Ruszala-Mallon, F E Durr

Cancer Res. 1984 Jun;44(6):2363-7.

PMID: 6426780

1

Comparative Molecular Pharmacology in Leukemic L1210 Cells of the Anthracene Anticancer Drugs Mitoxantrone and Bisantrene

G T Bowden, R Roberts, D S Alberts, Y M Peng, D Garcia

Cancer Res. 1985 Oct;45(10):4915-20.

PMID: 4027978

1

Disposition of Bisantrene in Humans and Rabbits: Evidence for Intravascular Deposition of Drug as a Cause of Phlebitis

G Powis, J S Kovach

Cancer Res. 1983 Feb;43(2):925-9.

PMID: 6848203

1

Phase I Clinical Investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] Dihydrochloride With Correlative in Vitro Human Tumor Clonogenic Assay

D S Alberts, C Mackel, R Pocelinko, S E Salmon

Cancer Res. 1982 Mar;42(3):1170-5.

PMID: 7037174

1

The Effects of Bisantrene on Human Platelets

M E Rybak, B Badstubner, T Griffin

Invest New Drugs. 1986;4(2):119-25.

PMID: 3015826

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode